These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24604684)

  • 21. Quantitative changes in botulinum toxin a treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm.
    Snir M; Weinberger D; Bourla D; Kristal-Shalit O; Dotan G; Axer-Siegel R
    Am J Ophthalmol; 2003 Jul; 136(1):99-105. PubMed ID: 12834676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm.
    Gill HS; Kraft SP
    Can J Neurol Sci; 2010 Sep; 37(5):631-6. PubMed ID: 21059510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life in patients with blepharospasm.
    Biuk D; Karin AA; Matić S; Barać J; Benasić T; Stiglmayer N
    Coll Antropol; 2013 Mar; 37(1):29-33. PubMed ID: 23697247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
    Wu CJ; Shen JH; Chen Y; Lian YJ
    Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much?
    Pang AL; O'Day J
    Clin Exp Ophthalmol; 2006 Jul; 34(5):441-4. PubMed ID: 16872340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm.
    Park DI; Shin HM; Lee SY; Lew H
    Acta Ophthalmol; 2013 Mar; 91(2):e108-12. PubMed ID: 23425111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.
    Li XH; Lin SC; Hu YF; Liu LY; Liu JB; Hong YC
    Eye Sci; 2012 Dec; 27(4):178-81. PubMed ID: 23225838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demographic and clinical features of patients with blepharospasm in southern Taiwan: a university hospital-based study.
    Hwang WJ
    Acta Neurol Taiwan; 2012 Sep; 21(3):108-14. PubMed ID: 23196730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
    Badarny S; Susel Z; Honigman S
    Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
    Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
    Oliveira FC; Oliveira GC; Cariello AJ; Felberg S; Osaki MH
    Arq Bras Oftalmol; 2010; 73(5):405-8. PubMed ID: 21225122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A; Barman CR; Prabhakar S
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin type A therapy for blepharospasm.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004900. PubMed ID: 15674969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.
    Lee S; Park S; Lew H
    Korean J Ophthalmol; 2018 Feb; 32(1):1-7. PubMed ID: 29376224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm.
    Jost WH; Kohl A
    J Neurol; 2001 Apr; 248 Suppl 1():21-4. PubMed ID: 11357234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with long-term treatment with albumin-supplemented botulinum toxin type A.
    Mohammadi B; Kollewe K; Wegener M; Bigalke H; Dengler R
    J Neural Transm (Vienna); 2009 Apr; 116(4):437-41. PubMed ID: 19319477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
    Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
    Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myobloc for the treatment of benign essential blepharospasm in patients refractory to botox.
    Dutton JJ; White JJ; Richard MJ
    Ophthalmic Plast Reconstr Surg; 2006; 22(3):173-7. PubMed ID: 16714924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.